Post-progression survival in advanced non-small cell lung cancer treated with anti-PD-1/PDL-1 monotherapy: progression after durable clinical benefit versus primary resistance

Ivan Pourmir, Reza Elaidi, Zineb Maaradji, Hortense de Saint Basile, Monivann Ung, Benoit Gazeau, Laure Fournier, Bastien Rance, Laure Gibault, Mohammed Ismaili, Elizabeth Fabre
doi: https://doi.org/10.1101/2023.03.09.23287023
Back to top
Posted March 13, 2023.
Download PDF

Supplementary Material

Data/Code
Email
Post-progression survival in advanced non-small cell lung cancer treated with anti-PD-1/PDL-1 monotherapy: progression after durable clinical benefit versus primary resistance
Ivan Pourmir, Reza Elaidi, Zineb Maaradji, Hortense de Saint Basile, Monivann Ung, Benoit Gazeau, Laure Fournier, Bastien Rance, Laure Gibault, Mohammed Ismaili, Elizabeth Fabre
medRxiv 2023.03.09.23287023; doi: https://doi.org/10.1101/2023.03.09.23287023
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area